Parkinson's disease. Parkinson's disease
Conditions
Interventions
Intervention 1: control group : The people in the control group will be treated with treadmill exercise for 6 weeks. they will walk on treadmill in all four directions. Exercises in the control group
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients with idiopathic Parkinson's disease according to United Kingdom(UK)Bank patients in Hoehn and Yahr scale (H&Y I-III) stages of Parkinson's disease patients should be MED on state patients should be able to independent walking at least for 6 min based on Unified Parkinson's Disease Rating Scale (UPDRS) Montreal Cognitive Assessment (MOCA)=24 for cognitive system
Exclusion criteria
Exclusion criteria: other neurological disorders such as CVA, Alzheimer, severe neuropathic impairments A history of any serious orthopedic problems such as surgery or fractures that prevent you from walking on the treadmill Existence of any severe respiratory and pulmonary diseases that prevent the intervention protocol Having a history of heart failure or coronary heart disease and stroke that prevents the intervention protocol Existence of hearing and vision impairment that prevents the correct performance of tests History of head and neck surgery History of Deep Brain Stimulation History of malignant diseases that prevent the intervention protocol Musculoskeletal pain that prevents the intervention protocol Participate in exercise programs such as treadmills for at least the past two months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Walking speed. Timepoint: before intervention, immediately after 6 weeks of intervention, after 2 moths from the end of intervention. Method of measurement: 6 min walking test.;Stride length. Timepoint: before intervention, immediately after 6 weeks of intervention, after 2 moths from the end of intervention. Method of measurement: meters.;Motor system function. Timepoint: before intervention, immediately after 6 weeks of intervention, after 2 moths from the end of intervention. Method of measurement: Unified Parkinson's Disease rating Scale(UPDRS III).;Cognitive function. Timepoint: before intervention, immediately after 6 weeks of intervention, after 2 moths from the end of intervention•. Method of measurement: MOCA test.;The percentage difference between stride length and walking speed. Timepoint: before intervention, immediately after 6 weeks of intervention, after 2 moths from the end of intervention•. Method of measurement: Dual task cost methods(DTcost). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: before intervention, immediately after 6 weeks of intervention, after 2 moths from the end of intervention•. Method of measurement: PDQ39 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Fallahzadeh
Shiraz University of Medical Sciences
Outcome results
None listed